(Adds Outlook)
Looking ahead, for the full year, Orthofix Medical Inc. (OFIX) raised its lower end of sales guidance to $790 million to $795 million from the earlier outlook of $785 million to $795 million. Analysts, on average, expect the firm to register revenue of $790.82 million, for the year.
Q1 Results:
Orthofix Medical revealed Loss for first quarter that decreased from the same period last year but missed the Street estimates.
The company's earnings totaled -$36.020 million, or -$0.95 per share. This compares with -$60.938 million, or -$1.71 per share, in last year's first quarter.
Analysts on average had expected the company to earn -$0.33 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 7.7% to $188.608 million from $175.204 million last year.
Orthofix Medical Inc. earnings at a glance (GAAP) :
-Earnings (Q1): -$36.020 Mln. vs. -$60.938 Mln. last year.-EPS (Q1): -$0.95 vs. -$1.71 last year.-Revenue (Q1): $188.608 Mln vs. $175.204 Mln last year.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.